Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the

A G Semb1, T K Kvien, A H Aastveit

  • 1Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. a-semb@diakonsyk.no

Insights

Patients with rheumatoid arthritis (RA) have a 1.6 times higher risk of acute myocardial infarction (AMI) and ischaemic stroke (IS). Cholesterol and triglycerides predict cardiovascular events in the general population but not consistently in RA patients.

Area of Science:

  • Cardiovascular epidemiology
  • Rheumatology
  • Lipid metabolism

Background:

  • Rheumatoid arthritis (RA) is associated with increased cardiovascular disease (CVD) risk.
  • The predictive value of lipid profiles for CVD events in RA patients remains incompletely understood.

Purpose of the Study:

  • To investigate the incidence of acute myocardial infarction (AMI) and ischaemic stroke (IS) in individuals with and without RA.
  • To assess the predictive capacity of total cholesterol (TC) and triglycerides (TG) for AMI and IS in both RA patients and controls.

Main Methods:

  • The Apolipoprotein MOrtality RISk (AMORIS) Study cohort of 480,406 individuals, including 1,779 with RA, was followed for a median of 11.8 years.
  • Cox regression analysis was employed to calculate hazard ratios (HR) per standard deviation (SD) increase in TC or TG, adjusted for age, diabetes, and hypertension.

Main Results:

  • Individuals with RA exhibited significantly lower TC and TG levels compared to those without RA.
  • Despite lower lipid levels, RA patients had a 1.6-fold higher rate of AMI and IS.
  • TC was a significant predictor of IS in RA patients (HR/SD 1.20, p=0.02) and nearly significant for AMI (HR/SD 1.13, p=0.07).
  • TG showed a weak association with IS (HR/SD 1.13, p=0.06) but not AMI.
  • In contrast, both TC and TG were significant predictors of AMI and IS in individuals without RA.

Conclusions:

  • Patients with RA experience a substantially higher incidence of AMI and IS compared to the general population.
  • While TC and TG are established predictors of cardiovascular events in non-RA individuals, their predictive utility in RA patients is inconsistent.
  • Further research is warranted to elucidate the specific mechanisms driving cardiovascular risk in RA.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...